agilon health Reports Third Quarter 2026 Results
agilon health reported Q3 2026 revenue of $1.52 billion, up 6% year-over-year, swinging to net income of $35 million from a $110 million loss a year earlier. The medical services expense ratio improved to 88.5% from 104.0%, aided by favorable burden-of-illness performance, payor contracting, and favorable claims development; Adjusted EBITDA reached $64 million versus negative $91 million. Membership declined 8% YoY to 566,000, reflecting deliberate market exits and a profitability-first contracting approach.
Key figures
- Eps
- 1.97
- Revenue
- 1519486000
- Guidance
- FY26 total revenues $5,870M-$5,890M (from $5,775M-$5,860M); Adjusted EBITDA $145M-$155M (from $75M-$95M); MSER 90.3%-90.5% (from 91.4%-91.9%)
- Revenue Yoy
- 6%
- Mser
- 88.5%
- Net income
- 34912000
- Total debt
- $32 million
- Total members
- 566000
- Adjusted ebitda
- 63684000
- Prior year mser
- 104.0%
- Total members yoy
- (8%)
- Medicare advantage members
- 454000
- Cash and marketable securities
- $312 million
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.